IMA — ImageneBio, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1835579 ·
Last close
$3.90
Market Cap
$48.58M
52W High
$7.89
52W Low
$3.01
ADV30
15,323
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 0 | — | -17,309,000 | -15,620,000 | 142,541,000 | 84,853,000 | 14,403,000 |
| Jun 2026 | 0 | — | -11,784,000 | -10,178,000 | 152,045,000 | 94,677,000 | 9,971,000 |
| Mar 2026 | 0 | — | -12,079,000 | -10,619,000 | 136,682,000 | 76,048,000 | 13,355,000 |
| Dec 2025 | 0 | — | -8,504,000 | -6,908,000 | 152,976,000 | 94,532,000 | 19,837,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-40,612,000
Investing CF
$-2,535,000
Financing CF
$24,886,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-5.40
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-266,470,000
Inventory
—
Receivables
$1,296,000
ST Investments
$41,744,000
EBIT TTM
$-49,676,000
Pretax Income TTM
$-43,555,000
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$0
EBITDA
$-58,366,500
Free Cash Flow
$-23,211,624
Enterprise Value
$-89,175,720
Total Cash
$136,152,992
Total Debt
$1,912,000
Shares Out
12,456,281
Trailing EPS
$-2.11
Book Value
$11.91
ROE
-82.7%
ROA
-43.1%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 800,000 | -48,451,000 | -45,349,000 | 152,976,000 | 19,837,000 | 133,139,000 | -47,844,000 |
| Dec 2024 | 3,500,000 | -37,000,000 | -36,568,000 | 15,922,000 | 176,487,000 | -160,565,000 | -21,319,000 |
| Dec 2023 | 7,962,000 | -21,925,000 | -21,148,000 | 31,245,000 | 157,353,000 | -126,108,000 | -18,233,000 |
TTM Snapshot
Revenues TTM
$800,000
NetIncome TTM
$-54,760,000
OpCashFlow TTM
—
Assets (Latest)
$152,045,000
Forward EPS
$-3.36
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INKT | MiNK Therapeutics, Inc. | $47.67M | $9.28 | — |
| SGMOQ | SANGAMO THERAPEUTICS, INC | $45.57M | $0.11 | — |
| OKYO | OKYO Pharma Ltd | $57.99M | $1.11 | — |
| PMCB | PharmaCyte Biotech, Inc. | $58.19M | $5.42 | — |
| ELOX | Eloxx Pharmaceuticals, Inc. | $40.34M | $11.74 | — |
News headlines (Yahoo Finance, 1h cache)
ImageneBio Reports Third Quarter 2026 Financial Results
2026-11-09 21:05 · Yahoo
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-10-02 20:30 · Yahoo
ImageneBio to Participate in H.C. Wainwright 28th Annual Global Investment Conference in New York
2026-09-08 20:30 · Yahoo
ImageneBio Reports Second Quarter 2026 Financial Results
2026-08-05 12:00 · Yahoo
ImageneBio Appoints Matt Robbins as General Counsel
2026-07-07 11:00 · Yahoo
ImageneBio Announces $30 Million Private Placement
2026-04-13 11:00 · Yahoo
ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York
2026-05-27 20:30 · Yahoo
ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update
2026-05-07 20:05 · Yahoo
Imax announces $28M opening weekend for Amazon/MGM/s ‘Project Hail Mary’
2026-03-24 12:35 · Yahoo
ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer
2026-02-10 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.